Avion Wealth Biotechnology

Avion Wealth

$439 Million
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
UTHR United Therapeutics Corp	$13.7B	$23,000 0.01% of portfolio	82	Q2 2025 New
EXEL Exelixis, Inc.	$12.1B	$14,000 0.0% of portfolio	323	Q2 2025 New
VRTX Vertex Pharmaceuticals Inc	$99.5B	$13,000 0.0% of portfolio	31	Q2 2025 New
ALNY Alnylam Pharmaceuticals, Inc.	$52.9B	$12,000 0.0% of portfolio	38	Q2 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$8,000 0.0% of portfolio	500	Q2 2025 New
INCY Incyte Corp	$18.2B	$6,000 0.0% of portfolio	92	Q2 2025 New
REGN Regeneron Pharmaceuticals, Inc.	$59.7B	$6,000 0.0% of portfolio	13	Q2 2025 New
ROIV Roivant Sciences Ltd.	$8.15B	$5,000 0.0% of portfolio	500	Q2 2025 New
ABUS Arbutus Biopharma Corp	$510M	$4,000 0.0% of portfolio	1,500	Q2 2025 New
ARQT Arcutis Biotherapeutics, Inc.	$887M	$4,000 0.0% of portfolio	335	Q2 2025 New
IBRX Immunity Bio, Inc.	$989M	$3,000 0.0% of portfolio	1,219	Q2 2025 New
INSM Insmed Inc	$16.5B	$3,000 0.0% of portfolio	36	Q2 2025 New
MRNA Moderna, Inc.	$10B	$3,000 0.0% of portfolio	131	Q2 2025 New
VKTX Viking Therapeutics, Inc.	$3.06B	$3,000 0.0% of portfolio	121	Q2 2025 New
TECH Bio Techne Corp	$2.07B	$2,000 0.0% of portfolio	51	Q2 2025 New
GERN Geron Corp	$510M	$2,000 0.0% of portfolio	2,000	Q2 2025 New
KOD Kodiak Sciences Inc.	$443M	$2,000 0.0% of portfolio	591	Q2 2025 New
RVMD Revolution Medicines, Inc.	$3.09B	$2,000 0.0% of portfolio	69	Q2 2025 New
ADPT Adaptive Biotechnologies Corp	$1.81B	$1,000 0.0% of portfolio	140	Q2 2025 New
FOLD Amicus Therapeutics, Inc.	$1.96B	$1,000 0.0% of portfolio	223	Q2 2025 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.88B	$1,000 0.0% of portfolio	126	Q2 2025 New
BMRN Biomarin Pharmaceutical Inc	$10.6B	$1,000 0.0% of portfolio	36	Q2 2025 New
CORT Corcept Therapeutics Inc	$7.88B	$1,000 0.0% of portfolio	23	Q2 2025 New
HALO Halozyme Therapeutics, Inc.	$8.95B	$1,000 0.0% of portfolio	27	Q2 2025 New
IDYA Ideaya Biosciences, Inc.	$1.13B	$1,000 0.0% of portfolio	85	Q2 2025 New
NTLA Intellia Therapeutics, Inc.	$825M	$1,000 0.0% of portfolio	149	Q2 2025 New
LXRX Lexicon Pharmaceuticals, Inc.	$200M	$1,000 0.0% of portfolio	1,333	Q2 2025 New
LGND Ligand Pharmaceuticals Inc	$2.58B	$1,000 0.0% of portfolio	9	Q2 2025 New
SLS Sellas Life Sciences Group, Inc.	$33.1M	$1,000 0.0% of portfolio	573	Q2 2025 New
ETNB 89bio, Inc.	$420M	$0 0.0% of portfolio	72	Q2 2025 New
ANIX Anixa Biosciences Inc	$93.2M	$0 0.0% of portfolio	200	Q2 2025 New
RCUS Arcus Biosciences, Inc.	$698M	$0 0.0% of portfolio	64	Q2 2025 New
BNTX Bio N Tech Se	$26.9B	$0 0.0% of portfolio	5	Q2 2025 New
CLDX Celldex Therapeutics, Inc.	$1.11B	$0 0.0% of portfolio	24	Q2 2025 New
CHRS Coherus Bio Sciences, Inc.	$71.5M	$0 0.0% of portfolio	660	Q2 2025 New
CRNX Crinetics Pharmaceuticals, Inc.	$1.53B	$0 0.0% of portfolio	16	Q2 2025 New
CYTK Cytokinetics Inc	$3.23B	$0 0.0% of portfolio	12	Q2 2025 New
DNLI Denali Therapeutics Inc.	$1.77B	$0 0.0% of portfolio	40	Q2 2025 New
FATE Fate Therapeutics Inc	$91.2M	$0 0.0% of portfolio	625	Q2 2025 New
INVA Innoviva, Inc.	$1.4B	$0 0.0% of portfolio	34	Q2 2025 New
KROS Keros Therapeutics, Inc.	$353M	$0 0.0% of portfolio	36	Q2 2025 New
KRYS Krystal Biotech, Inc.	$3.69B	$0 0.0% of portfolio	4	Q2 2025 New
MDXG Mimedx Group, Inc.	$821M	$0 0.0% of portfolio	72	Q2 2025 New
NVCT Nuvectis Pharma, Inc.	$100M	$0 0.0% of portfolio	56	Q2 2025 New
PTCT Ptc Therapeutics, Inc.	$3.24B	$0 0.0% of portfolio	11	Q2 2025 New
RLAY Relay Therapeutics, Inc.	$403M	$0 0.0% of portfolio	136	Q2 2025 New
SRPT Sarepta Therapeutics, Inc.	$1.6B	$0 0.0% of portfolio	8	Q2 2025 New
STRO Sutro Biopharma, Inc.	$40.7M	$0 0.0% of portfolio	716	Q2 2025 New
SNDX Syndax Pharmaceuticals Inc	$734M	$0 0.0% of portfolio	100	Q2 2025 New
RARE Ultragenyx Pharmaceutical Inc.	$1.97B	$0 0.0% of portfolio	15	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.